24 unknown. 24 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 24 | Unknown 24 |
| Phase 2 | 4 | Unknown 4 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms Accelerated iTBS - Schizophrenia; Negative Type | Phase 3 | Unknown | Institute of Mental Health, Singapore | 40 | 2024-04-01 | 2024-04-08 |
| Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia WID-RGC20(Cariprazine) 3mg/day, WID-RGC20(Cariprazine) 6mg/day, Placebo for WID-RGC20(Cariprazine) 3mg/day or 6mg/day - Schizophrenia | Phase 3 | Unknown | Whanin Pharmaceutical Company | 342 | 2021-11-19 | 2021-12-22 |
| SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia Clozapine, MECT, DBS - Treatment-resistant Schizophrenia | Phase 3 | Unknown | Shanghai Mental Health Center | 162 | 2020-12-01 | 2020-08-27 |
| Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia Cholecalciferol, Placebo - Schizophrenia | Phase 3 | Unknown | Universitas Padjadjaran | 40 | 2020-04-15 | 2020-04-02 |
| Estradiol as add-on to Antipsychotics Estradiol, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Unknown | Tangent Data | 100 | 2019-12-02 | 2020-05-26 |
| A Study of Staccato Loxapine (ADASUVE®) for Inhalation Inhaled loxapine, Inhaled placebo - Psychomotor Agitation, Schizophrenia | Phase 3 | Unknown | Lee's Pharmaceutical Limited | 150 | 2019-12-01 | 2019-11-05 |
| Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Pyridoxine, Cobalamin, Placebo Oral Tablet - Schizophrenia, Drug Induced Movement Disorder, Unspecified | Phase 2 / Phase 3 | Unknown | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | 45 | 2019-09-03 | 2019-12-18 |
| rTMS Treatment for Positive and Negative Symptoms of Schizophrenia rTMS - Schizophrenia | Phase 2 / Phase 3 | Unknown | St. Joseph's Healthcare Hamilton | 20 | 2016-02-01 | 2019-04-22 |
| Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia Minocycline, Placebo, Probiotics - Schizophrenia | Phase 3 | Unknown | Beer Yaakov - Ness Ziona Mental Health Center | 40 | 2015-01-01 | 2016-09-20 |
| Famotidine in Schizophrenia Famotidine, Placebo - Schizophrenia | Phase 2 / Phase 3 | Unknown | Jesper Ekelund | 140 | 2014-03-01 | 2015-04-14 |
| Computerized Cognitive Training for Schizophrenia in Brazil Computerized cognitive training - Schizophrenia | Phase 3 | Unknown | Universidade Federal do Rio de Janeiro | 100 | 2014-01-01 | 2018-01-17 |
| Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia Memantine, Placebo - Schizophrenia | Phase 3 | Unknown | National Taiwan University Hospital | 120 | 2014-01-01 | 2016-07-12 |
| Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia Iloperidone, Risperidone - Schizophrenia | Phase 3 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 288 | 2013-11-01 | 2015-05-27 |
| Repetitive Transcranial Magnetic Stimulation for First-episode Schizophrenia Patients active Risperidone and active rTMS, active rTMS and sham Risperidone, sham rTMS and active Risperidone - Schizophrenia | Phase 3 | Unknown | Xijing Hospital | 60 | 2011-06-01 | 2012-02-15 |
| Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder raloxifene, placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Unknown | Sheba Medical Center | 200 | 2011-03-01 | 2011-01-20 |
| Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder minocycline, pramipexole, acetylsalicylic acid - Schizophrenia, Schizoaffective Disorder | Phase 3 | Unknown | Sheba Medical Center | 400 | 2011-03-01 | 2011-03-23 |
| Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia Amantadine, Placebo - Schizophrenia | Phase 3 | Unknown | Hospital de Clinicas de Porto Alegre | 40 | 2010-05-01 | 2011-02-16 |
| Clinical Benefits of Seroquel XR in Anxiety Disorder Quetiapine XR - Schizophrenia, Anxiety | Phase 3 | Unknown | Corporation de Recherche en Neuropsycho Pharmacologie de Quebec | 40 | 2008-12-01 | 2012-08-27 |
| Transcranial Magnetic Stimulation (TMS) in Schizophrenia DEEP TMS H1 coil, Deep H1 coil TMS - Schizophrenia | Phase 2 / Phase 3 | Unknown | BeerYaakov Mental Health Center | 20 | 2008-10-01 | 2010-03-03 |
| Oxygen Therapy in Schizophrenia oxygen - Chronic Schizophrenia | Phase 3 | Unknown | Beersheva Mental Health Center | 20 | 2008-01-01 | 2008-05-28 |
Showing 20 of 24. Sign in to see all of them.
Psychotic Disorders (5) · Anxiety Disorders (1) · Bipolar Disorder (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Hyperprolactinemia (1) · Inflammation (1) · Neurobehavioral Manifestations (1) · Psychomotor Agitation (1) · Schizophrenia, Paranoid (1) · Schizophrenia, Treatment-Resistant (1) · cyclopia sequence (1)
Mental Disorders (24) · Schizophrenia Spectrum and Other Psychotic Disorders (24) · Nervous System Diseases (3) · Neurocognitive Disorders (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Aberrant Motor Behavior in Dementia (1) · Behavior (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Dyskinesias (1)
Cognitive Behavioral Therapy (2) · Minocycline (2) · Amantadine (1) · Aspirin (1) · Bexarotene (1) · Bromocriptine (1) · Cholecalciferol (1) · Clozapine (1) · Estradiol (1) · Famotidine (1) · Loxapine (1) · Memantine (1) · Oxygen (1) · Pramipexole (1) · Probiotics (1)
Beersheva Mental Health Center (2) · Sheba Medical Center (2) · Beer Yaakov - Ness Ziona Mental Health Center (1) · BeerYaakov Mental Health Center (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · Corporation de Recherche en Neuropsycho Pharmacologie de Quebec (1) · Hospital de Clinicas de Porto Alegre (1) · Institute of Mental Health, Singapore (1) · Jesper Ekelund (1) · Lee's Pharmaceutical Limited (1) · National Taiwan University Hospital (1) · Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara (1) · Philipps University Marburg (1) · Shanghai Mental Health Center (1) · St. Joseph's Healthcare Hamilton (1)
Israel (6) · Brazil (3) · China (3) · Germany (3) · Canada (2) · Romania (2) · Finland (1) · Moldova (1) · Singapore (1) · South Korea (1) · Sweden (1) · Taiwan (1)
Mark Weiser, MD (2) · Andreas Bechdolf, Dr. (1) · Chen-Chung Liu, MD, PhD (1) · Clarissa S Gama, MD, PhD (1) · Dengtang Liu, MD (1) · Gary Chaimowitz, MD, FRCPC (1) · Jesper Ekelund, MD, PhD (1) · Lia LO Sanders, MD, PhD (1) · Mark Weiser, M.D. (1) · Michael Ritsner, MD (1) · Oded Rosenberg, M.D. (1) · Qingrong Tan, Ph.D (1) · Rafael Stryjer, MD (1) · Roch-Hugo Bouchard, MD, FRCPC (1)
PMID 10622350, PMID 11318766, PMID 11458304, PMID 1503131, PMID 15285956, PMID 18303488, PMID 2028808, PMID 21303566, PMID 22075649, PMID 22559192, PMID 22626057, PMID 23244442, PMID 2374885, PMID 25914107, PMID 28541645, PMID 28675695, PMID 33479775, PMID 35921506, PMID 447850, PMID 7726309, PMID 8532098, PMID 8783894, PMID 8817704, PMID 9000318, PMID 9707298
2023 (1)